​

InspireMD (NSPR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NSPR Stock Forecast

InspireMD (NSPR) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $4.75, with a high of $5.00 and a low of $4.50. This represents a 112.05% increase from the last price of $2.24.

High: $5 Avg: $4.75 Low: $4.5 Last Closed Price: $2.24

NSPR Stock Rating

InspireMD stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (85.71%), 1 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 6 Strong Sell Sell Hold Buy Strong Buy

NSPR Price Target Upside V Benchmarks

TypeNameUpside
StockInspireMD112.05%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks20.18%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$5.00
Last Closing Price$2.24$2.24$2.24
Upside/Downside--123.21%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 2511---2
Sep, 2511---2
Aug, 2511---2
Jul, 2511---2
Jun, 2511---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 11, 2024Frank TakkinenLake Street$5.00$3.1757.73%123.21%
Sep 17, 2024Adam MaederPiper Sandler$4.50$2.6172.41%100.89%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 11, 2024Lake StreetBuyinitialise
Sep 17, 2024Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 $1 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-6.97$-2.03$-2.35$-0.82$0.04---
Avg Forecast$-6.00$-2.30$-2.59$-0.87$-0.78$-1.38$-1.25$-0.37
High Forecast$-6.00$-2.30$-2.56$-0.86$-0.77$-1.36$-1.23$-0.36
Low Forecast$-6.00$-2.30$-2.62$-0.88$-0.79$-1.40$-1.26$-0.38
Surprise %16.17%-11.74%-9.27%-5.75%-105.13%---

Revenue Forecast

$0 $10M $20M $30M $40M $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$2.48M$4.50M$5.17M$6.21M$7.01M---
Avg Forecast$3.50M$4.50M$5.00M$6.10M$6.90M$10.32M$26.78M$48.41M
High Forecast$3.50M$4.50M$5.04M$6.16M$6.97M$10.43M$27.07M$48.92M
Low Forecast$3.50M$4.50M$4.96M$6.03M$6.82M$10.21M$26.50M$47.90M
Surprise %-29.00%-0.11%3.42%1.76%1.63%---

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-10.54M$-14.92M$-18.49M$-19.92M$1.56M---
Avg Forecast$-145.61M$-55.82M$-62.85M$-21.11M$-18.93M$-33.20M$-30.21M$-8.98M
High Forecast$-145.61M$-55.82M$-62.20M$-20.82M$-18.67M$-33.03M$-29.80M$-8.86M
Low Forecast$-145.61M$-55.82M$-63.51M$-21.40M$-19.19M$-33.95M$-30.63M$-9.10M
Surprise %-92.76%-73.27%-70.58%-5.67%-108.23%---

NSPR Forecast FAQ

Is InspireMD stock a buy?

InspireMD stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that InspireMD is a favorable investment for most analysts.

What is InspireMD's price target?

InspireMD's price target, set by 7 Wall Street analysts, averages $4.75 over the next 12 months. The price target range spans from $4.5 at the low end to $5 at the high end, suggesting a potential 112.05% change from the previous closing price of $2.24.

How does InspireMD stock forecast compare to its benchmarks?

InspireMD's stock forecast shows a 112.05% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (20.18%).

What is the breakdown of analyst ratings for InspireMD over the past three months?

  • October 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is InspireMD’s EPS forecast?

InspireMD's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.38, marking a -3550.00% decrease from the reported $0.04 in 2024. Estimates for the following years are $-1.25 in 2026, and $-0.37 in 2027.

What is InspireMD’s revenue forecast?

InspireMD's average annual revenue forecast for its fiscal year ending in December 2025 is $10.32M, reflecting a 47.24% increase from the reported $7.01M in 2024. The forecast for 2026 is $26.78M, and $48.41M for 2027.

What is InspireMD’s net income forecast?

InspireMD's net income forecast for the fiscal year ending in December 2025 stands at $-33.2M, representing a -2232.31% decrease from the reported $1.56M in 2024. Projections indicate $-30.214M in 2026, and $-8.979M in 2027.